Effect of metformin on the formation of hepatic fibrosis in type 2 diabetic rats

Yaoxue Xuebao

Volumn 45, Issue 6, 2010, Pages 801-806

  Qiang, Gui Fen ^a   Zhang, Li ^a   Xuan, Qi ^b   Yang, Xiu Ying ^a   Shi, Li Li ^a   Zhang, Heng Ai ^a   Chen, Bai Nian ^a   Du, Guan Hua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic fibrosis; Metformin; Non alcoholic fatty liver disease; Type 2 diabetes

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GLUCOSE; METFORMIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; LIVER FIBROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ACTINS; ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; FEMALE; HEPATOCYTES; HYPOGLYCEMIC AGENTS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; METFORMIN; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77956867054     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. International Diabetes Federation. Latest diabetes figures paint grim global picture. Montreal, Canada, 19 October 2009 [EB]. http://www.idf.org/ latest-diabetes-figures-paint-grim-global-picture.
2. Ban CR, Twigg SM. Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers [J]. Vasc Health Risk Manag, 2008, 4: 575-596.
3. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities [J]. Gastroenterology, 2001, 120: 1183-1192.
4. Lin HZ, Yang SQ, Chuckaree C, et al. Metformin reverses fatty liver disease in obese, leptin-deficient mice [J]. Nat Med, 2000, 6: 998-1003.
5. Rafiq N, Younossi ZM. Effects of weight loss on nonalcoholic fatty liver disease [J]. Semin Liver Dis, 2008, 28: 427-433.
6. Utzschneider KM, Kahn SE. Review: the role of insulin resistance in nonalcoholic fatty liver disease [J]. J Clin Endocrinol Metab, 2006, 91: 4753-4761.
7. Adams LA, Harmsen S, St Sauver JL, et al. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study [J]. Am J Gastroenterol, 2010, in press.
8. Akyuz F, Demir K, Ozdil S, et al. The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease [J]. Dig Dis Sci, 2007, 52: 2359-2367.
9. Lingvay I, Raskin P, Szczepaniak LS. Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes [J]. J Diabetes Complications, 2007, 21: 137-142. (Pubitemid 46687072)
10. Mu SN, Kang LM, Xie YH. Establishment of rat model of type 2 diabetes [J]. Acta Acad Med Jiangxi 2009, 49: 16-19.
11. Wang CM, Li J, Lü XY, et al. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin [J]. Eur J Pharmacol, 2009, 620: 131-137.
12. Zhou JY, Zhou SW. Effect of berberine on PPARα/β/γ expression in type 2 diabetic rat retinae [J]. Acta Pharm Sin 2007, 42: 1243-1249.
13. Li XJ, Lei T, Gao JH. Detection of collagen in hypertrophic scars by picrosiriuspolarization method [J]. J First Mil Med Univ, 2002, 22: 217-219.
14. Li T, Fan Y, Liu F. Standard method on immunohistochemical image analytics of luminous density in immunohistochemistry image [J]. Chin J Anat, 2008, 31: 727-728.
15. Chen HH, Liu C. The 50 years history of metformin [J]. Int J Intern Med, 2008, 35: 573-577.
16. Nouchi T, Tanaka Y, Tsukada T, et al. Appearance of alpha-smooth-muscle- actin-positive cells in hepatic fibrosis [J]. Liver, 1991, 11: 100-105.
17. Lu LG, Zeng MD, Li JQ, et al. Effect of lipid on proliferation and activation of rat hepatic stellate cells (I) [J]. World J Gastroenterol, 1998, 4: 497-499.
18. Sugimoto R, Enjoji M, Kohjima M, et al. High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase [J]. Liver Int, 2005, 25: 1018-1026.
19. Saile B, Matthes N, EI Armouche H, et al. The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells [J]. Eur J Cell Biol, 2001, 80: 554-561.
20. Zhang C, Zhu Y, Wan J, et al. Effects of Ginkgo biloba extract on cell proliferation, cytokines and extracellular matrix of hepatic stellate cells [J]. Liver Int, 2006, 26: 1283-1290.
21. Hang HJ, Sheng JF. Apoptosis and liver fibrosis [J]. Inter J Epidemiol Infect Dis, 2006, 33: 118-120, 128.
22. Kashi MR, Torres DM, Harrison SA, et al. Current and emerging therapies in nonalcoholic fatty liver disease [J]. Semin Liver Dis, 2008, 28: 396-406.
23. Li ZZ, Berk M, McIntyre TM, et al. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase [J]. J Biol Chem, 2009, 284: 5637-5644.